Gut microbiota genome features associated with brain injury in extremely premature infants

Gut Microbes. 2024 Jan-Dec;16(1):2410479. doi: 10.1080/19490976.2024.2410479. Epub 2024 Oct 7.

Abstract

Severe brain damage is common among premature infants, and the gut microbiota has been implicated in its pathology. Although the order of colonizing bacteria is well described, the mechanisms underlying aberrant assembly of the gut microbiota remain elusive. Here, we employed long-read nanopore sequencing to assess abundances of microbial species and their functional genomic potential in stool samples from a cohort of 30 extremely premature infants. We identify several key microbial traits significantly associated with severe brain damage, such as the genomic potential for nitrate respiration and iron scavenging. Members of the Enterobacteriaceae were prevalent across the cohort and displayed a versatile metabolic potential, including pathogenic and nonpathogenic traits. Predominance of Enterobacter hormaechei and Klebsiella pneumoniae were associated with an overall loss of genomic functional redundancy as well as poor neurophysiological outcome. These findings reveal microbial traits that may be involved in exacerbating brain injury in extremely premature infants and provide suitable targets for therapeutic interventions.

Keywords: Enterobacteriaceae; Perinatal white matter injury; extremely premature infants; gut-microbiota-brain axis; inflammation; nanopore metagenomics; nitrate; siderophores.

MeSH terms

  • Bacteria / classification
  • Bacteria / genetics
  • Bacteria / isolation & purification
  • Bacteria / metabolism
  • Brain Injuries* / genetics
  • Brain Injuries* / microbiology
  • Cohort Studies
  • Feces* / microbiology
  • Female
  • Gastrointestinal Microbiome*
  • Genome, Bacterial
  • Humans
  • Infant, Extremely Premature*
  • Infant, Newborn
  • Male

Grants and funding

This project was funded by an inter-university cluster project grant between the University of Vienna and the Medical University of Vienna (“PreMiBraIn”), the European Research Council (Starting grant: FunKeyGut 741623), and the Austrian Science Fund (FWF) [P27831-B28, FG29; Cluster of Excellence 10.55776/COE7; 10.55776/FG29]. L.J.H. is supported by: Wellcome Trust Investigator Awards no. [220876/Z/20/Z].